These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor. Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557 [No Abstract] [Full Text] [Related]
27. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets. Halushka PV; Mais DE; Garvin M Eur J Pharmacol; 1986 Nov; 131(1):49-54. PubMed ID: 3816947 [TBL] [Abstract][Full Text] [Related]
28. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig. Mihara S; Hara S; Ueda M; Ide M; Fujimoto M Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812 [TBL] [Abstract][Full Text] [Related]
29. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Saussy DL; Mais DE; Knapp DR; Halushka PV Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641 [TBL] [Abstract][Full Text] [Related]
30. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets. Hanasaki K; Nakano T; Arita H Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543 [TBL] [Abstract][Full Text] [Related]
31. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats. Mallarkey G; Smith GM Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648 [TBL] [Abstract][Full Text] [Related]
32. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets. Jaschonek K; Faul C; Weisenberger H; Schmidt H; Renn W Prog Clin Biol Res; 1989; 301():327-33. PubMed ID: 2529551 [No Abstract] [Full Text] [Related]
33. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
34. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588 [TBL] [Abstract][Full Text] [Related]
35. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response. Thierauch KH; Gabriel D; Prior G; Schillinger E Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362 [TBL] [Abstract][Full Text] [Related]
36. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481 [TBL] [Abstract][Full Text] [Related]
37. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612 [TBL] [Abstract][Full Text] [Related]
38. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Okwu AK; Mais DE; Halushka PV Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. Booth RF; Honey AC; Lad N; Tuffin DP; Wade PJ Br J Pharmacol; 1989 Feb; 96(2):395-405. PubMed ID: 2522336 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]